Hisato Igarashi

5.5k total citations
100 papers, 3.1k citations indexed

About

Hisato Igarashi is a scholar working on Oncology, Epidemiology and Surgery. According to data from OpenAlex, Hisato Igarashi has authored 100 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 56 papers in Oncology, 51 papers in Epidemiology and 43 papers in Surgery. Recurrent topics in Hisato Igarashi's work include Neuroendocrine Tumor Research Advances (48 papers), Pancreatic and Hepatic Oncology Research (38 papers) and Pancreatitis Pathology and Treatment (35 papers). Hisato Igarashi is often cited by papers focused on Neuroendocrine Tumor Research Advances (48 papers), Pancreatic and Hepatic Oncology Research (38 papers) and Pancreatitis Pathology and Treatment (35 papers). Hisato Igarashi collaborates with scholars based in Japan, United States and Canada. Hisato Igarashi's co-authors include Tetsuhide Ito, Robert T. Jensen, Ryoichi Takayanagi, Masao Tanaka, Kazuhiko Nakamura, Tetsuhide Ito, Ken Kawabe, Masayuki Imamura, Nao Fujimori and Izumi Komoto and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Oncology.

In The Last Decade

Hisato Igarashi

95 papers receiving 3.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hisato Igarashi Japan 30 1.8k 1.6k 872 799 679 100 3.1k
Patricia Grabowski Germany 28 845 0.5× 562 0.4× 276 0.3× 563 0.7× 717 1.1× 75 2.2k
Cornelis J.M. Lips Netherlands 37 960 0.5× 913 0.6× 1.0k 1.2× 472 0.6× 1.8k 2.7× 96 4.5k
Hiroshi Inoué Japan 29 490 0.3× 363 0.2× 652 0.7× 293 0.4× 1.0k 1.5× 188 3.2k
Knut Dietzmann Germany 24 339 0.2× 428 0.3× 180 0.2× 397 0.5× 1.0k 1.5× 90 2.0k
Dueng‐Yuan Hueng Taiwan 27 263 0.1× 395 0.2× 318 0.4× 294 0.4× 807 1.2× 123 2.0k
Marily Theodoropoulou Germany 34 369 0.2× 857 0.5× 928 1.1× 362 0.5× 1.2k 1.7× 99 3.6k
Haruo Iguchi Japan 27 1.2k 0.6× 269 0.2× 490 0.6× 73 0.1× 676 1.0× 107 2.6k
Masatoshi Ichihara Japan 32 762 0.4× 202 0.1× 1.1k 1.3× 110 0.1× 1.5k 2.2× 82 3.4k
Jiang Wu China 24 464 0.3× 303 0.2× 282 0.3× 118 0.1× 405 0.6× 101 1.9k
Bangalore A. Chandramouli India 24 219 0.1× 330 0.2× 349 0.4× 256 0.3× 621 0.9× 54 1.7k

Countries citing papers authored by Hisato Igarashi

Since Specialization
Citations

This map shows the geographic impact of Hisato Igarashi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hisato Igarashi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hisato Igarashi more than expected).

Fields of papers citing papers by Hisato Igarashi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hisato Igarashi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hisato Igarashi. The network helps show where Hisato Igarashi may publish in the future.

Co-authorship network of co-authors of Hisato Igarashi

This figure shows the co-authorship network connecting the top 25 collaborators of Hisato Igarashi. A scholar is included among the top collaborators of Hisato Igarashi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hisato Igarashi. Hisato Igarashi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tanabe, Wataru, Hisato Igarashi, Kaoru Seiriki, et al.. (2023). Long-lasting anti-despair and anti-anhedonia effects of (S)-norketamine in social isolation-reared mice. Journal of Pharmacological Sciences. 154(2). 72–76. 2 indexed citations
2.
Komoto, Izumi, Norihiro Kokudo, Taku Aoki, et al.. (2022). Phase I/II study of streptozocin monotherapy in Japanese patients with unresectable or metastatic gastroenteropancreatic neuroendocrine tumors. Japanese Journal of Clinical Oncology. 52(7). 716–724. 4 indexed citations
3.
Seiriki, Kaoru, Atsushi Kasai, Takanobu Nakazawa, et al.. (2019). Whole-brain block-face serial microscopy tomography at subcellular resolution using FAST. Nature Protocols. 14(5). 1509–1529. 34 indexed citations
4.
Ueda, Keijiro, Ken Kawabe, Lingaku Lee, et al.. (2017). Diagnostic Performance of 48-Hour Fasting Test and Insulin Surrogates in Patients With Suspected Insulinoma. Pancreas. 46(4). 476–481. 6 indexed citations
5.
Eguchi, Hidetoshi, Hiroki Yamaue, Michiaki Unno, et al.. (2016). Clinicopathological Characteristics of Young Patients With Pancreatic Cancer. Pancreas. 45(10). 1411–1417. 25 indexed citations
6.
Ueda, Keijiro, Toshiyuki Suzuki, Lingaku Lee, et al.. (2016). Streptozocin monotherapy (Daily schedule) for Japanese patients with advanced pancreatic neuroendocrine tumors: A single-center experience. Pancreatology. 16(4). S112–S112.
7.
Ito, Tetsuhide, Hisato Igarashi, Kazuhiko Nakamura, Takuji Okusaka, & Masayuki Imamura. (2015). [Trends of epidemiology of pancreatic endocrine tumors: a nationwide survey analysis in Japan].. PubMed. 73 Suppl 3. 316–20. 1 indexed citations
8.
Lee, Lingaku, Hisato Igarashi, Masayuki Hijioka, et al.. (2014). Formation mechanism of pancreatic pseudocyst associated with autoimmune pancreatitis and efficacy of corticosteroid therapy: Considerations from 12 cases. Suizo. 29(4). 711–720. 1 indexed citations
9.
Nagayoshi, Yosuke, Teppei Aso, Takao Ohtsuka, et al.. (2013). Peroral pancreatoscopy using the SpyGlass system for the assessment of intraductal papillary mucinous neoplasm of the pancreas. Journal of Hepato-Biliary-Pancreatic Sciences. 21(6). 410–417. 44 indexed citations
10.
Nakamura, Taichi, Tetsuhide Ito, Masayuki Hijioka, et al.. (2013). PSCs and GLP-1R: occurrence in normal pancreas, acute/chronic pancreatitis and effect of their activation by a GLP-1R agonist. Laboratory Investigation. 94(1). 63–78. 25 indexed citations
11.
Okusaka, Takuji, Tetsuhide Ito, Toshirou Nishida, et al.. (2012). Phase II study of sunitinib (SU) in Japanese patients with unresectable or metastatic, well-differentiated pancreatic neuroendocrine tumor (NET).. Journal of Clinical Oncology. 30(4_suppl). 381–381. 4 indexed citations
12.
Nakamura, Taichi, Tetsuhide Ito, Hisato Igarashi, et al.. (2012). Cytosolic Double-Stranded DNA as a Damage-Associated Molecular Pattern Induces the Inflammatory Response in Rat Pancreatic Stellate Cells: A Plausible Mechanism for Tissue Injury-Associated Pancreatitis. International Journal of Inflammation. 2012. 1–12. 12 indexed citations
13.
Igarashi, Hisato, Tetsuhide Ito, Takamasa Oono, et al.. (2012). Relationship between pancreatic and/or extrapancreatic lesions and serum IgG and IgG4 levels in IgG4‐related diseases. Journal of Digestive Diseases. 13(5). 274–279. 8 indexed citations
14.
Fujimori, Nao, Taichi Nakamura, Hisato Igarashi, et al.. (2012). The Current Strategy for Managing Pancreatic Neuroendocrine Tumors in Multiple Endocrine Neoplasia Type 1. Gut and Liver. 6(3). 287–294. 26 indexed citations
15.
Ito, Tetsuhide, Takamasa Oono, Ken Kawabe, et al.. (2008). Fractalkine and TGF-β1 levels reflect the severity of chronic pancreatitis in humans. World Journal of Gastroenterology. 14(42). 6488–6488. 28 indexed citations
16.
Ito, Tetsuhide, Ken Kawabe, Yoshiyuki Arita, et al.. (2007). Evaluation of pancreatic endocrine and exocrine function in patients with autoimmune pancreatitis. Suizo. 22(4). 521–523. 5 indexed citations
17.
Ito, Tetsuhide, Takamasa Oono, Terumasa Hisano, et al.. (2005). VIP attenuation of the severity of experimental pancreatitis is due to VPAC1 receptor-mediated inhibition of cytokine production.. PubMed. 30(1). 62–70. 39 indexed citations
18.
Igarashi, Hisato, et al.. (2002). Elucidation of the Vasoactive Intestinal Peptide Pharmacophore for VPAC2 Receptors in Human and Rat and Comparison to the Pharmacophore for VPAC1 Receptors. Journal of Pharmacology and Experimental Therapeutics. 303(2). 445–460. 29 indexed citations
19.
Igarashi, Hisato, Tetsuhide Ito, Samuel A. Mantey, et al.. (2002). Elucidation of Vasoactive Intestinal Peptide Pharmacophore for VPAC1 Receptors in Human, Rat, and Guinea Pig. Journal of Pharmacology and Experimental Therapeutics. 301(1). 37–50. 37 indexed citations
20.
Mantey, Samuel A., David H. Coy, Tapas K. Pradhan, et al.. (2001). Rational Design of a Peptide Agonist That Interacts Selectively with the Orphan Receptor, Bombesin Receptor Subtype 3. Journal of Biological Chemistry. 276(12). 9219–9229. 59 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026